Valneva SE
VSE:VLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Valneva SE
VSE:VLA
|
FR |
|
Talgo SA
F:XTG
|
ES |
|
C
|
Cyfrowy Polsat SA
WSE:CPS
|
PL |
|
I
|
Inversora Juramento SA
BCBA:INVJ
|
AR |
|
A
|
Aurora Design PCL
SET:AURA
|
TH |
Intrinsic Value
Is VLA undervalued or overvalued?
See the intrinsic value estimate for 
Valneva SE and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Valneva Does
Valneva is a vaccine company. It develops, makes, and sells vaccines that help prevent infectious diseases, with a focus on travel and other niche areas where public health agencies and doctors need specific protection rather than broad everyday medicines. Its best-known products include vaccines for diseases such as Japanese encephalitis, cholera, and other travel-related infections, along with vaccine candidates still in development.
- Headquarters
- France FR
- Employees
- 674
- IPO date
- Jun 28, 2007
Revenue & Expenses Breakdown
Valneva SE
Earnings Waterfall
Valneva SE
The intrinsic value for Valneva SE (VLA) under the Base Case is hidden EUR.
Compared with the current market price of 2.556 EUR, the stock appears hidden.